Acarbose
Links shared publicly online about this topic
Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes | Cardiology
touchcardiology.com — “Dysglycaemic disease is one of the most important health issues facing the world in the 21st century. Patients with type 2 diabetes and individuals with prediabetes are at risk of developing macrovascular and microvascular complications.” View full resource at touchcardiology.com
Most Recently Shared on September 15, 2009 at 12:05 pm By:
Touch Cardiology Health News and Cardiology
Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes http://ow.ly/oEP1
Endocrinology Article | Diabetes Mellitus, Type 2
mdlinx.com — “Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes” View full resource at mdlinx.com
Most Recently Shared on June 9, 2011 at 12:03 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insuli... http://bit.ly/iznys8 #diabetes
Mylan gets FDA approval of generic Precose tablets - Bloomberg
bloomberg.com — “CANONSBURG, Pa. (AP) --" The Food and Drug Administration approved three new dose amounts for Mylan's generic version of Bayer's Precose tablets, the company said Tuesday.” View full resource at bloomberg.com
Most Recently Shared on January 19, 2011 at 3:34 pm By:
eyeonfda Pharma and Health Lawyer
RT @the_pillbook: FDA approves generic Precose (acarbose); to be available immediately. http://bit.ly/eBc2ih
Danish analysis finds higher risk for CV death with certain glucose-lowering medications
endocrinetoday.com — “American Diabetes Association's 69th Scientific Sessions A nationwide Danish study showed that gliclazide, repaglinide and acarbose had sim” View full resource at endocrinetoday.com
Most Recently Shared on June 7, 2009 at 2:25 pm By:
ADA: Danish analysis finds higher risk for CV death with certain glucose-lowering medications ... http://tinyurl.com/pjk3h8
Diabetes Drugs: Alpha-Glucosidase Inhibitors :: Diabetes Self-Management
diabetesselfmanagement.com — “Alpha-glucosidase inhibitors, a class of drugs also known as “starch blockers,†function by slowing the absorption of certain carbohydrates in the gastrointestinal tract. two drugs in this class — acarbose (brand name precose) and miglitol (glyset) — are approved in the united states, while two others — voglibose (volix and others) and emiglitate — are available only outside of the united states... ” View full resource at diabetesselfmanagement.com
Most Recently Shared on September 8, 2009 at 8:29 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Alpha-glucosidase inhibitors take the spotlight in Mark Marino's miniseries on diabetes drugs. http://bit.ly/11E8Nj
Diabetes prevention: Meta-analysis finds glitazones superior to other oral antidiabetic drug classes - - Drug Topics
drugtopics.modernmedicine.com — “A systematic review assessing the comparative effectiveness of oral anti-diabetic drugs for preventing patients at high risk from progressing to type 2 diabetes has found glitazones (pioglitazone, rosiglitazone), biguanides (metformin), and alpha-glucosidase inhibitors (AGIs; acarbose, voglibose) reduced the relative risk of diabetes by as much as 63%, whereas insulin secretagogues (sulfonylureas and glinides) had no effect.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on July 6, 2010 at 9:00 am By:
Diabetes prevention: Meta-analysis finds glitazones superior to other oral antidiabetic drug classes: A systematic... http://bit.ly/9E7NMw
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Touch Cardiology
Touch Cardio journals provides up-to-date news & information within the Cardiovascular industry, including info on heart disease, ecg & surgery advances
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
Advertisement
